Hence the identified ETSP from expression of EFEMP1 variant construct E5 would give stronger tumor suppression than the parental EFEMP1 in TMC by targeting EGFR and angiogenesis, and also would gain a new tumor-suppression function by targeting NOTCH. The gene discussed is EFEMP1; the disease is neoplasm.